Market Tracker

08/16 11:07am ET

Clovis Oncology Inc (NASDAQ:CLVS)

71.86
BATS BZX Real-Time Price
As of 11:07am ET
 -0.02 / -0.03%
Today’s Change
16.58
Today|||52-Week Range
99.45
+61.77%
Year-to-Date

Today’s Trading

Previous close71.88
Today’s open71.67
Day’s range70.67 - 72.18
Volume15,568
Average volume (3 months)1,842,405
Market cap$3.5B
Dividend yield--
Data as of 11:07am ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+21.20%
Earnings growth (next 5 years)-84.45%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.17+0.48%
OPKOPKO Health Inc+0.03+0.41%
SAGESAGE Therapeutics In...+0.28+0.33%
PTLAPortola Pharmaceutic...-0.02-0.04%
Data as of 11:07am ET, 08/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts